Pegintron combined with Vx-950 (Telaprevir)

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Renal Disorder Other Serious 1/13/2012 57 Female 2/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinal Haemorrhage Other Serious 12/18/2011 70 Female 1/11/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Vomiting Hospitalization 1/18/2012 50 Female 2/6/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Renal Failure Acute Hospitalization 2/8/2012 58 Female 4/25/2013 Other Health Professional Jp
Primary
Concomitant
Renal Impairment Other Serious 12/22/2011 45 Male 2/6/2013 Other Health Professional Jp
Primary
Concomitant
Drug Eruption Hospitalization 2/19/2012 57 Male 2/26/2013 Other Health Professional Jp
Primary
Concomitant
Renal Disorder Other Serious 1/12/2012 45 Male 2/6/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Hospitalization 2/27/2012 67 Male 5/20/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Nausea Hospitalization 1/27/2012 67 Female 5/31/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Renal Disorder Other Serious 1/20/2012 53 Male 2/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 2/21/2012 51 Male 2/4/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinopathy Other Serious 2/3/2012 60 Female 1/4/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 2/14/2012 49 Male 3/20/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Stomatitis Hospitalization 3/17/2012 62 Female 2/7/2013 Other Health Professional Jp
Primary
Secondary
Rash Other Serious 3/23/2012 53 Male 146 lb 12/7/2012 Physician Br
Primary
Concomitant
Drug Eruption Hospitalization 2/4/2012 55 Female 2/7/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Nausea Hospitalization 3/16/2012 63 Male 5/10/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Interstitial Lung Disease Other Serious 3/24/2012 70 Male 4/2/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 2/19/2012 39 Female 2/11/2013 Other Health Professional Jp
Primary
Secondary
Retinopathy Other Serious 2/24/2012 57 Male 2/7/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Renal Disorder Other Serious 2/22/2012 66 Male 1/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Urinary Tract Infection Other Serious 2/16/2012 54 Female 11/20/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Liver Disorder Other Serious 4/17/2012 68 Male 12/21/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Renal Disorder Other Serious 1/19/2012 63 Male 2/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Mania Other Serious 4/1/2012 60 Female 5/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinopathy Other Serious 3/5/2012 60 Male 4/26/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 3/28/2012 58 Female 1/30/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Other Serious 5/2/2012 59 Male 2/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Vomiting Other Serious 4/9/2012 67 Male 2/4/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Erythema Other Serious 5/13/2012 60 Male 5/30/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 3/22/2012 56 Male 6/11/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Presyncope Hospitalization 5/1/2012 63 Male 1/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinopathy Other Serious 2/13/2012 63 Male 2/6/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 5/23/2012 66 Female 2/4/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased 5/22/2012 49 Female 1/18/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutropenia Other Serious 6/27/2012 63 Female 3/4/2013 Other Health Professional Jp
Primary
Secondary
Erythema Other Serious 7/5/2012 54 Male 3/29/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Generalised Other Serious 6/26/2012 48 Male 1/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 2/15/2012 59 Male 3/25/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinopathy Other Serious 3/7/2012 71 Female 2/1/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinal Haemorrhage Other Serious 5/18/2012 62 Male 5/14/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Drug Eruption Other Serious 5/25/2012 52 Male 1/31/2013 Other Health Professional Jp
Primary
Concomitant
Erythema Multiforme Hospitalization 6/4/2012 56 Male 2/20/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Other Serious 7/23/2012 60 Male 3/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 7/25/2012 46 Male 12/27/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Hospitalization 6/27/2012 66 Female 2/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Pancreatitis Acute Other Serious 8/7/2012 65 Female 4/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Sinus Disorder 7/27/2012 Female 2/26/2013 Consumer Us
Primary
Secondary
Heat Illness Death 8/17/2012 67 Female 5/14/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 3/6/2012 50 Male 4/1/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 8/8/2012 49 Female 3/29/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Interstitial Lung Disease Other Serious 3/23/2012 51 Male 4/8/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Other Serious 8/2/2012 61 Male 4/11/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinal Haemorrhage Other Serious 3/3/2012 65 Male 1/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 3/16/2012 62 Male 2/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Drug Eruption Hospitalization 8/7/2012 66 Male 6/25/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Loss Of Consciousness Other Serious 3/19/2012 68 Male 5/14/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 3/22/2012 64 Male 3/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Interstitial Lung Disease Other Serious 6/14/2012 57 Male 3/29/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Vomiting Hospitalization 6/2/2012 55 Male 3/11/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Xeroderma Hospitalization 2/2/2012 65 Male 2/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Hospitalization 7/5/2012 61 Female 3/22/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Malaise Other Serious 2/21/2012 62 Female 2/25/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Pleural Effusion Hospitalization 5/14/2012 67 Male 12/28/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 3/13/2012 62 Female 1/4/2013 Other Health Professional Jp
Primary
Secondary
Drug Eruption Hospitalization 7/23/2012 41 Male 3/12/2013 Other Health Professional Jp
Primary
Secondary
Malaise Hospitalization 5/8/2012 47 Male 11/8/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Gastric Ulcer Other Serious 8/6/2012 63 Male 3/25/2013 Other Health Professional Jp
Primary
Concomitant
Platelet Count Decreased Other Serious 4/11/2012 61 Female 2/1/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Retinopathy Other Serious 5/9/2012 56 Male 12/3/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Platelet Count Decreased Hospitalization 3/30/2012 52 Male 3/14/2013 Other Health Professional Jp
Primary
Secondary
Neutrophil Count Decreased Other Serious 7/31/2012 53 Female 1/23/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 3/14/2012 66 Female 2/15/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Weight Decreased 9/16/2012 54 Female 130 lb 2/19/2013 Consumer Us
Primary
Secondary
Concomitant
White Blood Cell Count Decreased 8/2012 Female 11/29/2012 Consumer Us
Primary
Secondary
Thrombocytopenia Hospitalization 9/24/2012 Male 183 lb 12/18/2012 Physician De
Primary
Secondary
Concomitant
Optic Neuritis Other Serious 4/20/2012 51 Male 2/26/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Pneumonia Bacterial Hospitalization 9/14/2012 66 Male 3/29/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash 7/2/2012 62 Male 1/28/2013 Other Health Professional Jp
Primary
Secondary
Neutrophil Count Decreased Hospitalization 7/30/2012 58 Female 1/31/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Septic Shock Death 10/1/2012 65 Female 3/13/2013 Other Health Professional Jp
Primary
Concomitant
Optic Neuropathy Other Serious 4/25/2012 63 Male 2/1/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 3/19/2012 57 Female 2/13/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 8/14/2012 68 Female 2/14/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Granulocyte Count Decreased Other Serious 8/20/2012 42 Male 3/6/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Other Serious 4/12/2012 48 Male 3/25/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 9/18/2012 52 Female 2/25/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Upper Respiratory Tract Infection Other Serious 9/21/2012 58 Female 3/6/2013 Consumer Us
Primary
Secondary
Drug Eruption Hospitalization 10/15/2012 66 Male 3/8/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Other Serious 8/29/2012 58 Male 12/6/2012 Other Health Professional Jp
Primary
Secondary
White Blood Cell Count Decreased Other Serious 3/13/2012 67 Male 3/6/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Platelet Count Decreased Other Serious 5/26/2012 50 Male 1/15/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 4/28/2012 52 Female 1/25/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 6/19/2012 64 Male 2/4/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 8/3/2012 63 Female 3/19/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 4/23/2012 64 Male 2/22/2013 Other Health Professional Jp
Primary
Secondary
White Blood Cell Count Decreased Other Serious 9/12/2012 67 Male 3/15/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash 10/2012 Male 2/14/2013 Consumer Us
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/23/2012 53 Female 11/14/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Hospitalization 4/11/2012 53 Male 2/14/2013 Other Health Professional Jp
Primary
Concomitant
Rash Other Serious 2/8/2012 60 Female 11/14/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Vomiting 2012 Male 1/29/2013 Consumer Us
Primary
Secondary
Decreased Appetite Other Serious 3/6/2012 59 Female 11/19/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Erythema 4/17/2012 59 Female 11/19/2012 Other Health Professional Jp
Primary
Concomitant
Vomiting Hospitalization 3/29/2012 73 Female 11/21/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 9/19/2012 50 Male 2/11/2013 Other Health Professional Jp
Primary
Secondary
Retinopathy Other Serious 5/18/2012 56 Female 2/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Cough 7/12/2012 47 Female 2/12/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Herpes Zoster Other Serious 8/29/2012 54 Male 3/25/2013 Other Health Professional Jp
Primary
Secondary
Malaise 2/7/2012 71 Female 11/26/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Headache 11/2012 Female 2/21/2013 Consumer Us
Primary
Secondary
Neutrophil Count Decreased Hospitalization 2/14/2012 60 Male 11/27/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Other Serious 9/10/2012 62 Female 2/22/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 8/11/2012 51 Male 2/11/2013 Other Health Professional Jp
Primary
Secondary
Neutrophil Count Decreased Other Serious 8/17/2012 54 Female 2/28/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Pulmonary Congestion Male 187 lb 1/30/2013 Consumer Us
Primary
Secondary
Platelet Count Decreased 12/1/2012 59 Male 194 lb 2/14/2013 Consumer Us
Primary
Secondary
Concomitant
Retinopathy Other Serious 9/28/2012 64 Male 12/19/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Macular Degeneration Other Serious 3/16/2012 57 Male 12/21/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Stomatitis Other Serious 3/17/2012 62 Male 12/31/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Other Serious 7/17/2012 61 Female 3/19/2013 Other Health Professional Jp
Primary
Secondary
Nausea 1/2013 Female 2/5/2013 Consumer Us
Primary
Secondary
Death Death 7/2012 28 Female 2/6/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Rash Papular 1/29/2013 Female 110 lb 2/15/2013 Consumer Us
Primary
Secondary
Concomitant
Renal Disorder Other Serious 2/2/2012 65 Female 2/6/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Stupor 2013 Male 276 lb 2/6/2013 Consumer Us
Primary
Secondary
Concomitant
Rash Macular 1/21/2012 Male 2/6/2013 Consumer Us
Primary
Secondary
Neutrophil Count Decreased Other Serious 2/22/2012 64 Female 2/5/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Other Serious 4/11/2012 35 Male 2/11/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Vomiting Female 2/8/2013 Consumer Us
Primary
Secondary
Concomitant
Headache Male 2/14/2013 Consumer Us
Primary
Secondary
Rash Male 2/11/2013 Consumer Us
Primary
Secondary
Vomiting 1/2013 Female 1/29/2013 Consumer Us
Primary
Secondary
Vomiting 1/2013 Female 1/29/2013 Consumer Us
Primary
Secondary
Diarrhoea 1/29/2013 60 Male 220 lb 2/25/2013 Consumer Us
Primary
Secondary
Concomitant
Chest Pain 2012 Male 2/8/2013 Consumer Us
Primary
Secondary
White Blood Cell Count Decreased Other Serious 5/7/2012 54 Male 2/27/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Adverse Event 1/24/2013 59 Male 1/28/2013 Physician Us
Primary
Secondary
Concomitant
Influenza Like Illness Male 3/5/2013 Consumer Us
Primary
Secondary
Influenza Like Illness Male 205 lb 3/7/2013 Consumer Us
Primary
Secondary
Rash Pruritic Male 3/7/2013 Consumer Us
Primary
Secondary
Platelet Count Decreased Hospitalization Male 3/8/2013 Consumer Us
Primary
Secondary
Bronchopneumonia Hospitalization 3/4/2013 60 Female 152 lb 3/27/2013 Physician Rs
Primary
Secondary
Influenza Like Illness 1/2013 Male 2/12/2013 Consumer Us
Primary
Secondary
Retinal Haemorrhage Other Serious 3/27/2012 63 Male 3/14/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Weight Decreased 2012 Male 3/18/2013 Consumer Us
Primary
Secondary
Wheezing 2013 Male 3/20/2013 Consumer Us
Primary
Secondary
Vomiting Male 3/21/2013 Consumer Us
Primary
Secondary
Pyrexia 2/26/2013 58 Male 3/22/2013 Consumer Us
Primary
Secondary
Drug Reaction With Eosinophilia And Systemic Symptoms Hospitalization 1/20/2012 65 Male 12/28/2012 Other Health Professional Jp
Primary
Secondary
Concomitant

Drug Data